Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: 10Q.... Warrants outstanding...

"Cashless basis" suggests to me that the cost associated with the conversion was equivalent to the difference between number of warrants and shares, or 272,500 shares. If my math serves me right, that means the total cost for conversion was $0.012/warrant.

IMO

Best regards.

Share
New Message
Please login to post a reply